Avelumab in G2-3 NET

NCT03278379 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors

Interventions

DRUG: Avelumab

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]